Generalized Anxiety Disorder: Symptoms, Treatments & Prognosis
This paper provides a broad overview of Generalized Anxiety Disorder (GAD), a condition in which chronic, excessive worry significantly disrupts daily functioning. The paper examines the disorder's defining symptoms, its estimated causes — including genetics, brain chemistry, and environmental stress — and its prevalence in the United States. It then surveys the primary medication options (benzodiazepines and SSRIs), the functional and economic limitations the disorder imposes, and available treatment interventions such as cognitive behavioral therapy and exposure therapy. The paper concludes with a discussion of support groups and the generally optimistic prognosis available to patients who pursue a comprehensive treatment plan.
- Introduction to Generalized Anxiety Disorder: Definition, symptoms, causes, and U.S. prevalence
- Medications for GAD: Antidepressants, benzodiazepines, and SSRIs explained
- Functional Limitations: Economic and personal impact of GAD on daily life
- Treatment Interventions: CBT, exposure therapy, and combined approaches
- Support Groups: Role of peer support in coping with anxiety
- Patient Prognosis: Optimistic outlook with comprehensive treatment plan
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- Uses a firsthand patient quotation at the outset to ground the clinical discussion in a relatable human experience, immediately engaging the reader.
- Moves logically from definition and causes through medications and functional impact to treatment and prognosis, providing a coherent clinical narrative.
- Supports claims with concrete statistics (e.g., 4 million U.S. sufferers, $42 billion annual economic burden), adding credibility to the discussion.
Key academic technique demonstrated
The paper demonstrates the use of authoritative institutional sources — the National Institute of Mental Health, the Anxiety and Depression Association of America, and WebMD — to validate clinical claims. Embedding a patient's first-person account alongside epidemiological data effectively bridges qualitative experience and quantitative evidence, a technique often used in health-science writing to make technical content accessible.
Structure breakdown
The paper is organized into six clearly labeled sections: an introduction defining GAD and its symptoms and causes; a medications section covering anxiolytics and SSRIs; a section on functional and economic limitations; a treatment-interventions section covering behavioral therapies; a section on peer support groups; and a closing prognosis section. This structure follows a standard clinical-overview format, moving from problem identification to management and outcome.
Introduction to Generalized Anxiety Disorder
Nearly everyone deals with anxiety at some point in their lives. Anxiety is a natural response to many external stimuli and can actually be beneficial in many ways. However, there is a point at which anxiety can reach a level that is no longer a normal experience and can be overwhelming to an individual's life. One individual described the condition this way (National Institute of Mental Health, n.d.):
"I always thought I was just a worrier. I'd feel keyed up and unable to relax. At times it would come and go, and at times it would be constant. It could go on for days. I'd worry about what I was going to fix for a dinner party, or what would be a great present for somebody. I just couldn't let something go."
People with Generalized Anxiety Disorder (GAD) cannot seem to rid themselves of their concerns about everyday problems and tend to overreact to various environmental stressors. As a result, these individuals never feel relaxed and have difficulty coping with an array of situations. Physical symptoms may include fatigue, headaches, muscle tension, muscle aches, difficulty swallowing, trembling, twitching, irritability, sweating, nausea, lightheadedness, frequent urges to use the bathroom, shortness of breath, and hot flashes (National Institute of Mental Health, n.d.).
The causes of this disorder are not completely understood. However, a number of factors are considered relevant to the onset of GAD, including genetics, brain chemistry, and environmental stress (WebMD, n.d.). The average onset occurs shortly after an individual reaches the age of thirty. A doctor can screen for GAD or other anxiety disorders by asking a series of questions about how a person is able — or unable — to cope with stress. Generally, if symptoms occur more often than not over any six-month period, a doctor can make a diagnosis of the disorder. It is estimated that roughly four million people in the United States suffer from GAD in any given year.
Medications for GAD
A variety of medications can be prescribed for GAD. However, medications are not generally recommended unless the symptoms of the disorder are serious and significantly interfere with the patient's daily life. The most commonly prescribed medication types for GAD are antidepressants, anti-anxiety drugs, and selective serotonin reuptake inhibitors (SSRIs). Antidepressants are primarily used to treat depression but can also be effective for anxiety.
The most common drugs used to treat serious anxiety are known as anxiolytics, and these include drugs in the benzodiazepine family. The anxiety-relieving effects of these drugs are felt almost immediately; however, they carry a high potential for both physical and psychological dependence. The withdrawal symptoms from this class of drug can be quite dangerous — sometimes even deadly — if the medication is stopped suddenly. When a patient discontinues this type of drug, they must taper the dosage in a slow and controlled manner to avoid serious side effects.
A relatively newer class of drug, SSRIs, is used for a variety of disorders related to depression and anxiety. These drugs increase the amount of serotonin present in the brain, which functions to alter the neurological processes underlying mental health conditions.
Functional Limitations
There can be many functional limitations affecting someone who suffers from Generalized Anxiety Disorder, especially when the condition is severe. A person with GAD can be immobilized by stress and anxiety, causing them to miss work and disengage from daily life. Anxiety disorders cost the United States more than $42 billion a year — almost one-third of the country's $148 billion total mental health expenditure — according to "The Economic Burden of Anxiety Disorders," a study commissioned by the Anxiety and Depression Association of America (ADAA, n.d.). Furthermore, even when a person does not miss work due to anxiety, the disorder is associated with concentration difficulties that can diminish the quality of an individual's performance on the job.
Works Cited
ADAA. (n.d.). Facts & statistics. Retrieved from Anxiety and Depression Association of America: http://www.adaa.org/about-adaa/press-room/facts-statistics
National Institute of Mental Health. (n.d.). Generalized Anxiety Disorder (GAD). Retrieved from National Institute of Mental Health: http://www.nimh.nih.gov/health/topics/generalized-anxiety-disorder-gad/index.shtml
WebMD. (n.d.). Anxiety & panic disorders health center. Retrieved from WebMD: http://www.webmd.com/anxiety-panic/guide/generalized-anxiety-disorder
Create your account
Always verify citation format against your institution’s current style guide requirements.